Latest filing published 24 May 2023 for Aurinia Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
Joseph Patrick Hagan: trading record in brief
Joseph Patrick Hagan appears in our data through filings on Aurinia Pharmaceuticals Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 7 February 2018 and the latest from 23 May 2023.
Purchases make up the whole of the open-market record (2 purchases, €10k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 option exercise.
Most recently, on 24 May 2023, the filings show an option exercise in Aurinia Pharmaceuticals Inc. The last purchase on record was published on 15 October 2019, which is 2,583 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Joseph Patrick Hagan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,461 sharesCommon SharesTSXSEDI:4132977
- 2,000 shares@ CA$4.75562.2% of flowCommon SharesTSXSEDI:3438996Canonical exit: 13 Jan 2020 (T+90)
- 1,500 shares@ CA$3.868737.8% of flowCommon SharesTSXSEDI:3438995Canonical exit: 9 Jan 2020 (T+90)
- Common SharesTSXSEDI:3438992
4 of 4 declarations